Quantitative Analysis of Mutant Subclones in Chronic Myeloid Leukemia: Comparison of Different Methodological Approaches

Author： Preuner Sandra   Barna Agnes   Frommlet Florian   Czurda Stefan   Konstantin Byrgazov   Alikian Mary   Machova Polakova Katerina   Sacha Tomasz   Richter Johan   Lion Thomas   Gabriel Christian  

Publisher： MDPI

E-ISSN： 1422-0067|17|5|642-642

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.17, Iss.5, 2016-04, pp. : 642-642

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quantitative Proteomics to Characterize Specific Histone H2A Proteolysis in Chronic Lymphocytic Leukemia and the Myeloid THP-1 Cell Line

By Glibert Pieter   Vossaert Liesbeth   Van Steendam Katleen   Lambrecht Stijn   Van Nieuwerburgh Filip   Offner Fritz   Kipps Thomas   Dhaenens Maarten   Deforce Dieter  

International Journal of Molecular Sciences, Vol. 15, Iss. 6, 2014-05 ,pp. : 9407-9421

MDPI

Access to resources Recommend Favorite

Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia

By Polillo Marialuisa   Galimberti Sara   Baratè Claudia   Petrini Mario   Danesi Romano   Di Paolo Antonello  

International Journal of Molecular Sciences, Vol. 16, Iss. 9, 2015-09 ,pp. : 22811-22829

MDPI

Access to resources Recommend Favorite

Chemokines as a Conductor of Bone Marrow Microenvironment in Chronic Myeloid Leukemia

By Mukaida Naofumi   Tanabe Yamato   Baba Tomohisa  

International Journal of Molecular Sciences, Vol. 18, Iss. 8, 2017-08 ,pp. : 1824-1824

MDPI

Access to resources Recommend Favorite

Antiproliferative Effect of Aaptamine on Human Chronic Myeloid Leukemia K562 Cells

By Jin Meihua   Zhao Wennan   Zhang Yanwen   Kobayashi Motomasa   Duan Hongquan   Kong Dexin  

International Journal of Molecular Sciences, Vol. 12, Iss. 11, 2011-10 ,pp. : 7352-7359

MDPI

Access to resources Recommend Favorite

Minimally-Myelosuppressive Asparaginase-Containing Induction Regimen for Treatment of a Jehovah’s Witness with mutant IDH1/NPM1/NRAS Acute Myeloid Leukemia

By Emadi Ashkan   Bade Najeebah A.   Stevenson Brandi   Singh Zeba  

Pharmaceuticals, Vol. 9, Iss. 1, 2016-03 ,pp. : 12-12

MDPI

Access to resources Recommend Favorite